Center of Innovative Diagnostics and Therapeutics (CIRI GmbH) /ID# 209494

Frankfurt 60590

0 studies enrolling now · 1 studies all time

What they study most

Psoriatic Arthritis (PsA)

Studies at this site

• A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) — Completed